Cervical Fixation Surgery Cervical Collar for Management of Hirayama Disease: A Randomized Study
NCT ID: NCT05959980
Last Updated: 2024-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2023-10-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Is cervical stabilization surgery (Posterior cervical fixation) superior to conservative management in the form of cervical collar placement in patients with progressive Hirayama disease, observed at six months after intervention
Participants will have equal chance to:
* Undergo cervical fixation surgery
* Cervical collar management The investigators will study and compare the efficacy of both treatments upto six months after intervention
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Investigation of Thoracic Spinal Curvature and Mobility in Subjects With and Without Neck Pain: Cut-off Points
NCT02424058
Global Postural Reeducation Versus Neck Stabilization Training on Text Neck Syndrome.
NCT05249673
Investigation of the Efficacy of Thoracic Mobilization Exercises Performed in Addition to Core Stabilization Exercises in Individuals With Chronic Non-Specific Neck Pain
NCT06991140
Cervical Stability and Body Awareness in Migraine
NCT07116590
Does the Degree of Cervical Stenosis Affect Proprioception?
NCT06566573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Prospective randomized open blinded endpoint (PROBE), phase III study
2. Inclusion criteria:
All the following:
1. Age ≥ 18 years
2. Patients with Hirayama disease as per the following criteria (All of the following) (16):
1. Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion)
2. Progressive course, or initial progression followed by stationary course; and
3. No evidence of a compressive lesion of the spinal cord.
3. Disease duration of ≤4 years
4. Progression of clinical symptoms in the past six-months c. Exclusion criteria:
Any of the following:
1\) Refusal to consent for randomization 2) Not willing to come for three- and six-months follow-up e. Procedures at baseline:
1. Clinical, electrophysiology and autonomic function assessments:
After the clinical diagnosis by inclusion criteria, the patients will undergo a detailed clinical examination (as per the case record form (CRF), which includes power, autonomic features, grip strength), and the objective assessment of the electrophysiological parameters
2. Radiological assessment:
All patients will undergo MR imaging on a 1.5 T MR scanner (Optima 450w, General Electric, Milwaukee, USA), using an 8-channel cervical-thoracic-lumbar array spine coil. The imaging will include axial and sagittal T2-WIs and post-gadolinium T1+C in flexion, neutral and extension positions. In addition, DTI protocol will include sagittal and axial acquisition of cervical cord in neutral position. MR-DTI data will process on a dedicated workstation (Advantage Windows workstation, GE Healthcare, WI, USA) using commercially available software (Functool 14.3.01, GE HealthCare, WI, USA). After co-registration of raw images to correct the motion and distortion artefacts, the ADC and FA images will be generated. The mean, minimum and maximum values of FA and ADC will be recorded from region of maximum cord compression/ T2-hyperintensity.
The investogators will get a cervical spine radiograph at the time of discharge and at 6 months.
3. Surgical procedure:
The patients who are randomized to undergo posterior cervical fixation will be admitted in Neurosciences Centre, All India Institute of Medical Sciences, New Delhi. These patients will undergo routine preoperative work up, including routine blood investigations and a detailed preanesthetic checkup (PAC). These patients will undergo posterior cervical fixation in the form of cervical lateral mass screw fixation in extension without decompression under general anesthesia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical arm
Will undergo posterior cervical fixation surgery within 4 weeks of randomization
Posterior cervical fixation surgery
These patients will undergo posterior cervical fixation in the form of cervical lateral mass screw fixation in extension without decompression under general anesthesia.
Cervical collar arm
Will be given cervical collar for regular use
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Posterior cervical fixation surgery
These patients will undergo posterior cervical fixation in the form of cervical lateral mass screw fixation in extension without decompression under general anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Age ≥ 18 years
2. Patients with Hirayama disease as per the following criteria (All of the following) (16):
1. Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion)
2. Progressive course, or initial progression followed by stationary course; and
3. No evidence of a compressive lesion of the spinal cord.
3. Disease duration of ≤4 years
4. Progression of clinical symptoms in the past six-months
Exclusion Criteria
1. Refusal to consent for randomization
2. Not willing to come for three- and six-months follow-up
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
All India Institute of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deepti Vibha
Professor, Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deepti Vibha
Role: PRINCIPAL_INVESTIGATOR
AIIMS, New Delhi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deepti Vibha
New Delhi, National Capital Territory of Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC-60
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.